Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.7338
-0.0084 (-1.13%)
At close: Jan 9, 2026, 4:00 PM EST
0.7300
-0.0038 (-0.52%)
After-hours: Jan 9, 2026, 7:57 PM EST
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $13.62 million as of January 9, 2026. Its market cap has decreased by -12.84% in one year.
Market Cap
13.62M
Enterprise Value
124.64M
1-Year Change
-12.84%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $44.82M to $13.62M, a decrease of -69.60%. That is a compound annual growth rate of -4.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 13.62M | -7.23% |
| Dec 31, 2025 | 14.69M | -4.25% |
| Dec 31, 2024 | 15.34M | -6.42% |
| Dec 29, 2023 | 16.39M | -56.55% |
| Dec 30, 2022 | 37.73M | 26.22% |
| Dec 31, 2021 | 29.89M | -62.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |